Zeping Zuo

机构：Beijing Tongren Hospital, National Institutes of Pharmaceutical Research and Development (China)

发表论文 45 篇 · 总被引 836 次 · h-index 13

代表论文

• Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51 (2023 · Nature Communications · 被引 36)
• Network pharmacology and experimental verification to explore the anti-migraine mechanism of Yufeng Ningxin Tablet (2023 · Journal of Ethnopharmacology · 被引 22)
• Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill (2023 · Chinese Herbal Medicines · 被引 20)
• Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B (2023 · MedComm · 被引 17)
• Xianglian Zhixie Tablet Antagonizes Dextran Sulfate Sodium-Induced Ulcerative Colitis by Attenuating Systemic Inflammation and Modulating Gut Microbiota (2023 · Journal of Inflammation Research · 被引 11)
• Fuzi Lizhong Pill inhibited inflammatory response and promoted colon mucosal healing in dextran sulfate sodium-induced ulcerative colitis mice by down-regulating PI3K/AKT/NF-κB signaling pathway (2025 · Journal of Ethnopharmacology · 被引 10)